Background The occurrence of antibiotic‐resistant strains has been rapidly increasing due
to the wide use of antibiotics. To evaluate the current effects of antibiotic resistance on …

Background: We systematically reviewed all available data in the literature to determine the
overall eradication rates of currently advised Helicobacter pylori eradication regimens and to …

Background Information regarding the effects of drug resistance on therapies for
Helicobacter pylori is limited. Aims To determine the effect of drug resistance on the efficacy …

Background & Aims: The role of omeprazole in triple therapy and the impact of Helicobacter
pylori resistance on treatment outcome are not established. This study investigated the role …

Culture and susceptibility testing of Helicobacter pylori strains was performed in a large
multinational, multicenter randomized clinical trial. Culture was carried out on gastric biopsy …

Aim: To perform a meta‐analysis of studies comparing twice daily, one‐week triple therapy
with a proton pump inhibitor, clarithromycin (C) and amoxycillin (A)(PCA) vs. those using …

Objective: CYP2C19 polymorphisms have been inconsistently reported to associate with the
efficacy of proton pump inhibitor (PPI)‐based triple therapies for eradicating Helicobacter …

Treatment of Helicobacter pylori infection | The BMJ Skip to main content Intended for
healthcare professionals Access provided by Google Indexer Subscribe My Account My email …

Helicobacter pylori infection is the main cause of gastritis, gastroduodenal ulcers and gastric
cancer. H. pylori eradication has been shown to have a prophylactic effect against gastric …

Background: Although many of the currently available Helicobacter pylori eradication
regimens fail to cure 5%-12% of patients, an optimal re-treatment therapy for eradication …